These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1622434)

  • 1. Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys.
    Kato M; Furuhama K; Woolley AP; Ashby R; Fowler JS; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):367-73. PubMed ID: 1622434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys.
    Sugawara T; Yoshida M; Shimoda K; Takada S; Miyamoto M; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jul; 46(7):705-10. PubMed ID: 8842343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits.
    Inage F; Kato M; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits.
    Watanabe T; Fujikawa K; Harada S; Ohura K; Sasaki T; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):374-7. PubMed ID: 1622435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the new quinolone antibacterial agent levofloxacin on multiple organ carcinogenesis initiated with wide-spectrum carcinogens in rats.
    Kajimura T; Tojo H; Kudo G; Yamada M; Domon S; Nomura M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):390-5. PubMed ID: 1622438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals.
    Shimoda K; Akahane K; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jun; 46(6):625-8. PubMed ID: 8767355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-week sub-acute toxicity study of S-(-)-9-fluoro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl)-7-oxo-7H-pyrido-[1,2,3,-de] [1,4]benzoxazine-6- carboxylic acid hemihydrate (DR-3355) in CD rats and cynomolgus monkeys.
    Kato M; West HA; Ashby R; Virgo DM; Fowler JS; Furuhama K; Takayama S
    J Toxicol Sci; 1991 Feb; 16(1):29-48. PubMed ID: 1895350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmotoxicity and ototoxicity of the new quinolone antibacterial agent levofloxacin in Long Evans rats.
    Nomura M; Yamada M; Yamamura H; Kajimura T; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):398-403. PubMed ID: 1622440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice.
    Wagai N; Yoshida M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):404-5. PubMed ID: 1622441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Shimada H; Itoh S; Hattori C; Tada S; Matsuura Y
    Arzneimittelforschung; 1992 Mar; 43(3A):378-85. PubMed ID: 1622436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive toxicity of ofloxacin.
    Takayama S; Watanabe T; Akiyama Y; Ohura K; Harada S; Matsuhashi K; Mochida K; Yamashita N
    Arzneimittelforschung; 1986 Aug; 36(8):1244-8. PubMed ID: 3465327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-week oral toxicity studies of the new quinolone antibacterial agent cetefloxacin tosylate in rats and marmoset monkeys.
    Guzmán A; García C; Marín AP; Demestre I
    Arzneimittelforschung; 2001; 51(5):425-32. PubMed ID: 11413745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of the new quinolone antibacterial agent levofloxacin.
    Wagai N; Hattori H; Yamaguchi F; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):385-9. PubMed ID: 1622437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subchronic toxicity studies of the new quinolone antibacterial agent irloxacin in rodents.
    Guzmán A; García C; Demestre I
    Arzneimittelforschung; 1999 May; 49(5):448-56. PubMed ID: 10367108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic toxicity of the new quinolone antibacterial agent irloxacin in beagle dogs.
    Guzmán A; García C; Demestre I
    Arzneimittelforschung; 2000 May; 50(5):485-94. PubMed ID: 10858877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.